Chase Kelley

Associate, Life Sciences Research

Chase joined Foresite Capital in 2022 as an Associate on the Research team, where he focuses on identifying early-stage transformational technologies in the life sciences.

Chase received his Ph.D. in genetics and genomics as an NSF Graduate Fellow from University of Florida in the lab of Dr. Eric Wang, where he studied the intersection of subcellular RNA localization, repeat expansion disease mechanisms, and gene therapy engineering strategies.

Chase led and collaborated on studies in both experimental and computational biology, the latter of which included building high-throughput automated image analysis methods for single-molecule RNA imaging. He also participated in our first Foresite Fellows Program cohort.

Prior to his graduate studies, Chase worked as a research associate in protein and RNA engineering at Editas Medicine in Cambridge, MA, where he led projects on directed evolution of Cas9 and guide RNAs. He received his B.S. in chemical engineering and physics from Northeastern University in Boston, MA, and during his undergraduate training he built additional experience in nanoparticle drug delivery, protein engineering, and gene editing through internships in academia and industry.


  • PhD in genetics and genomics from the University of Florida in the lab of Prof. Eric Wang
  • Broad experience in RNA biology, genome editing, gene therapy, and computational biology
  • Participated in first cohort of Foresite Fellows Program